Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Early Release

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 31, Number 2—February 2025

Synopses
  • National Surveillance of Human Ehrlichiosis Caused by Ehrlichia ewingii, United States, 2013–2021
    S. N. Adams et al.
  • Two Human Cases of Fatal Meningoencephalitis Associated with Potosi and Lone Star Viruses, United States, 2020–2023
    C. Y. Chiu et al.
Research
  • Short-Lived Neutralizing Antibody Responses to Monkeypox Virus in Smallpox Vaccine–Naive Persons after JYNNEOS Vaccination
    K. Phipps et al.

    JYNNEOS, a third-generation smallpox vaccine, is integral to monkeypox virus (MPXV) control efforts, but the durability of this modified vaccinia Ankara–Bavarian Nordic (MVA-BN) vaccine’s effectiveness is undefined. We optimized and used a plaque reduction neutralization test (PRNT) with authentic clade IIa MPXV and vaccinia virus to assess antibody responses over 12 months in 8 donors vaccinated with 2 doses of JYNNEOS. One donor previously received the ACAM2000 vaccine; 7 donors were smallpox vaccine–naive. IgG responses of the donors to vaccinia virus (L1, B5, and A33) or MPXV (E8, H3, A35) antigens and PRNT titers to both viruses peaked at 8 weeks postvaccination and waned rapidly thereafter in naive donors. MPXV PRNT titers were especially low; no naive donors demonstrated 90% plaque reduction. These data indicate a need for improved correlates of MPXV immunity to enable MVA-BN durability studies, given that recent clinical data support MVA-BN vaccine efficacy against MPXV despite low antibody responses.

  • Cyclospora Genotypic Variations and Associated Epidemiologic Characteristics, United States, 2018–2021
    J. Shen et al.
  • Epidemiologic and Genomic Surveillance of Vibrio cholerae and Effectiveness of Single-Dose Oral Cholera Vaccine, Democratic Republic of the Congo
    C. George et al.

    We conducted 4 years of epidemiologic and genomic surveillance of single-dose effectiveness of a killed whole-cell oral cholera vaccine (kOCV) and Vibrio cholerae transmission in the Democratic Republic of the Congo. We enrolled 1,154 patients with diarrhea; 342 of those had culture-confirmed cholera. We performed whole-genome sequencing on clinical and water V. cholerae isolates from 200 patient households, which showed annual bimodal peaks of V. cholerae clade AFR10e infections. A large clonal cholera outbreak occurred 14 months after a kOCV campaign of >1 million doses, likely because of low (9%) vaccine coverage in informal settlements. Clinical and water isolates collected in the same household were closely related, suggesting person-to-person and water-to-person transmission. Single-dose kOCV vaccine effectiveness 24 months after vaccination was 59.8% (95% CI 19.7%–79.9%), suggesting modest single-dose kOCV protection. kOCV campaigns combined with water, sanitation, and hygiene programs should be used to reduce cholera in disease-endemic settings worldwide.

  • Respiratory Shedding of Infectious SARS-CoV-2 Omicron XBB.1.41.1 Lineage among Captive White-Tailed Deer, Texas, USA
    F. C. Ferreira et al.

    White-tailed deer (Odocoileus virginianus) have high value for research, conservation, agriculture, and recreation and might be key SARS-CoV-2 reservoirs. In November 2023, we sampled 15 female deer in a captive facility in Texas, USA. All deer had neutralizing antibodies to SARS-CoV-2; respiratory swab samples from 11 deer were SARS-CoV-2–positive by quantitative reverse transcription PCR, and 1 deer also had a positive rectal swab sample. Six of the 11 respiratory swab samples yielded infectious virus; replication kinetics of most samples displayed lower growth 24–48 hours postinfection in vitro than Omicron lineages isolated from humans in Texas in the same period. Virus growth was similar between groups by 72 hours, suggesting no strong attenuation of deer-derived virus. All deer viruses clustered in XBB Omicron clade and demonstrated more mutations than expected compared with contemporaneous viruses in humans, suggesting that crossing the species barrier was accompanied by a high substitution rate.

  • Prions in Muscles of Cervids with Chronic Wasting Disease, Norway
    T. T. Vuong et al.

    Chronic wasting disease (CWD) is an emerging prion disease in Nordic countries and has been detected in reindeer, moose, and red deer since 2016. CWD sporadically detected in moose and red deer in 3 Nordic countries demonstrated pathologic and strain characteristics different from CWD in reindeer, including an unexpected lack of prions outside the central nervous system as measured by standard diagnostic tests. Using protein misfolding cyclic amplification, we detected prions in the lymphoreticular system of moose and red deer with CWD in Norway and, remarkably, in muscles of both of those species and in CWD-infected reindeer. One moose lymph node and 1 moose muscle sample showed infectivity when experimentally transmitted to bank voles. Our findings highlight the systemic nature of CWD strains in Europe and raise questions regarding the risk of human exposure through edible tissues.

  • Streptococcus pyogenes emm Type 3.93 Emergence, the Netherlands and England
    M. A. Davies et al.
  • Contribution of Limited Molecular Testing to Low Ehrlichiosis Diagnosis in High Incidence Area, North Carolina, USA
    A. Siegler et al.

    Indirect immunofluorescence antibody assays have been the primary method for laboratory diagnosis of ehrlichiosis. Detection of Ehrlichia spp. DNA by using PCR is now widely available through commercial laboratories. To prepare for Ehrlichia spp. PCR introduction, we assessed ehrlichiosis testing practices, quantified the proportion of samples eligible for PCR testing, and estimated the potential effect of implementing PCR at the University of North Carolina health system in North Carolina, USA, which is in an area with a high-incidence of ehrlichiosis. We found <1% of patient samples underwent PCR testing, even though rates of serodiagnostic algorithm completion (testing of acute and convalescent samples) were low (18.4%). Our findings show a need to educate providers on diagnostic and treatment guidelines for ehrlichiosis and raise awareness of the availability and advantage of PCR testing.

  • Sudan Virus Persistence in Immune-Privileged Organs of Nonhuman Primates
    B. B. Beavis et al.

    After the 2022–2023 Sudan virus (SUDV) disease outbreak in Uganda, we studied SUDV persistence in nonhuman primates that had survived acute infection without therapeutic intervention. We identified SUDV persistence in the vitreous chamber and immediately adjacent tissue in the eyes as well as in the seminiferous tubules in the testes but not in common target organs typically infected during the acute phase of disease. Specifically, SUDV persists primarily in macrophages in the eyes and Sertoli cells in the testes. Ocular and testicular SUDV persistence in nonhuman primates is accompanied by tissue damage, including inflammatory cell invasion. Our study suggests that long-term follow-up efforts are needed to reduce possible recrudescent disease and reignition of outbreaks caused by virus persistence in human survivors of SUDV infection.

  • Global Epidemiology of Outbreaks of Unknown Cause Identified by Open-Source Intelligence, 2020–2022
    D. Honeyman et al.
Dispatches
Research Letters
  • Venezuelan Equine Encephalitis Virus Infection in Nonhuman Primate, Guatemala, 2023
    W. K. Jo et al.

    We isolated Venezuelan equine encephalitis virus (VEEV) subtype IE phylogenetically related to Gulf Coast strains in a spider monkey (Ateles geoffroyi) released from a rescue center in Guatemala. Serologic testing of 118 monkeys indicated no additional VEEV infections. Infection of a primate warrants intensified surveillance of VEEV transmission cycles in North America.

  • Sin Nombre Virus as Unlikely Reverse Zoonotic Threat
    J. Prévost et al.

    We inoculated clinical materials into deer mice to attempt isolation of Sin Nombre virus. We did not observe productive infection in the natural rodent reservoir. Genomic comparisons between rodent reservoirs and human disease may provide insight into hantavirus evolution and genetic determinants, but reverse zoonosis of Sin Nombre virus appears unlikely.

  • Acute Encephalopathy Associated with Human Adenovirus Type 14 Infection in 7-Year-Old Girl, Japan
    S. Mizuno et al.

    Only 2 cases of human adenovirus type 14 (HAdV-14) have been reported in Japan since 1980. We report a 7-year-old girl with acute encephalopathy associated with HAdV-14 infection genetically similar to strains from the United States. The patient had not had contact with international travelers. HAdV-14 surveillance should be strengthened in Japan.

  • Zika Virus Infection in Pregnant Traveler Returning to Denmark from Phuket, Thailand, 2024
    I. Rubin et al.

    We report a case of Zika virus (ZIKV) infection in a pregnant woman from Denmark who traveled to Thailand during her first trimester. Late in the second trimester, severe microcephaly was diagnosed in the fetus, and ZIKV infection was confirmed. Travelers and clinicians should be aware of ongoing ZIKV risk in Thailand.

  • Burkholderia pseudomallei Sequence Type 46 Transmission from Asia to Australia
    E. M. Meumann et al.

    Melioidosis is caused by the environmental pathogen Burkholderia pseudomallei. Among 1,331 patients with melioidosis during 1989–2023 in the Darwin Prospective Melioidosis Study in Australia, we identified 6 locally acquired cases caused by B. pseudomallei sequence type 46. Because of global transmission and expansion of endemicity, clinicians should increase awareness of melioidosis.

  • Ixodes scapularis Tick Parasitizing Dog in Dawson County, Montana, USA, 2023
    P. E. Stewart et al.

    In October 2023, a partially engorged female Ixodes tick was removed from a dog in Bozeman, Montana, USA, that had recently spent time in eastern Montana. The tick was identified as I. scapularis according to morphologic characteristics and genomic sequencing, suggesting an expanded geographic distribution requiring continued public health surveillance.

  • Henipavirus in Northern Short-Tailed Shrew, Alabama, USA
    R. H. Parry et al.

    RNA metagenomic analysis of tissues from 4 wild-caught northern short-tailed shrews in Alabama, USA, revealed a novel henipavirus (family Paramyxoviridae). Phylogenetic analysis supported the placement of the virus within the shrew henipavirus clade, related to human-infecting shrewborne henipaviruses. Our study results highlight the presence of henipavirus infections in North America.

  • Human Infection with Avian Influenza A(H9N2) Virus, Vietnam, April 2024
    M. Duong et al.

    In April 2024, Vietnam confirmed its first human case of influenza A(H9N2) in a 37-year-old man, marking a critical point in regional infectious disease monitoring and response. This case underscores the importance of robust surveillance systems and One Health collaboration in managing emerging zoonotic threats.

  • Bayou Hantavirus Cardiopulmonary Syndrome, Louisiana 2022–23
    E. Ortega et al.
  • Mycoplasma phocimorsus in Woman with Tendinous Panaritium after Cat Scratch, Denmark
    A. Skafte-Holm et al.

    A panaritium developed in a woman in Demark after her cat scratched her. Analysis of tissue by 16S rRNA gene sequencing revealed Mycoplasma phocimorsus, known to cause seal finger. The source of the bacterium likely transmitted by the cat is unknown, but awareness of potential zoonotic transmission from cats should be raised.

Books and Media
Etymologia
Online Reports
  • Arbovirus Epidemics as Global Health Imperative, Africa, 2023
    S. T. Bangoura et al.
  • Adaptive Design for Phase II/III Platform Trial of Lassa Fever Therapeutics
    J. Bourner et al.
About the Cover
  • A Pictorial Human Case of “Furious Rabies”
    A. Perciaccante et al.

Top

Volume 31, Number 3—March 2025

Synopsis
  • Corynebacterium diphtheriae Infections, South Africa, 2015–2023
    M. du Plessis et al.
Research
  • Mycobacterium nebraskense Isolated from Patients in Connecticut and Oregon, USA
    M. L. Metersky et al.
  • Genomic Characterization of Circulating Dengue Virus, Ethiopia, 2022–2023
    A. Abera et al.
  • High Prevalence of AtpE Mutations in Bedaquiline-Resistant Mycobacterium tuberculosis Isolates, Russia
    D. Zimenkov et al.
  • Effect of Prior Influenza A(H1N1)pdm09 Virus Infection on Pathogenesis of Human Influenza A(H5N1) Clade 2.3.4.4b Virus Isolate in Ferret Model
    X. Sun et al.
  • Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes
    E. V. Kurbatova et al.
  • Impact, Costs, and Cost-Effectiveness of Tuberculosis Outbreak Investigations, United States
    S. Shrestha et al.
Dispatches
  • Macrolide-Resistant Mycoplasma pneumoniae Infections among Children after COVID-19 Pandemic, Ohio, USA
    A. L. Leber et al.
  • Cefotaxime-Resistant Neisseria meningitidis ST-4821 Causing Fulminant Meningitis
    Y. Shao et al.
  • Reemergence of Brucella abortus, Israel, 2021
    S. Bardenstein et al.
Research Letters
  • Neurosarcocystosis in Patient with HIV-Induced Immunodeficiency
    T. Skarpengland et al.
  • Fluoroquinolone Resistance in Drug-Resistant Tuberculosis, Kharkiv, Ukraine, 2019–2023
    O. Konstantynovska et al.
  • Community-Acquired Pneumonia Caused by Avian Chlamydia abortus, the Netherlands
    J. Gooskens et al.
  • Evaluation of High-Dose Isoniazid Use in Multidrug-Resistant Tuberculosis Treatment
    V. Gerussi et al.
  • Lack of Competence of US Mosquito Species in Circulating Oropouche Virus
    A. F. Payne et al.

Top

The requested issue is not available.

The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
edit_01 ScholarOne Submission Portal
Issue Select
GO
GO

Spotlight Topics

 

 

Get Email Updates

To receive email updates about this page, enter your email address:

file_external